annual operating profit:
-$279.30M-$65.24M(-30.48%)Summary
- As of today (June 16, 2025), XENE annual operating income is -$279.30 million, with the most recent change of -$65.24 million (-30.48%) on December 31, 2024.
- During the last 3 years, XENE annual operating profit has fallen by -$200.31 million (-253.57%).
- XENE annual operating profit is now -2614.84% below its all-time high of $11.11 million, reached on December 31, 2014.
Performance
XENE Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$72.74M+$4.74M(+6.12%)Summary
- As of today (June 16, 2025), XENE quarterly operating income is -$72.74 million, with the most recent change of +$4.74 million (+6.12%) on March 31, 2025.
- Over the past year, XENE quarterly operating profit has dropped by -$13.70 million (-23.20%).
- XENE quarterly operating profit is now -939.83% below its all-time high of $8.66 million, reached on September 30, 2014.
Performance
XENE quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$293.00M-$13.70M(-4.90%)Summary
- As of today (June 16, 2025), XENE TTM operating income is -$293.00 million, with the most recent change of -$13.70 million (-4.90%) on March 31, 2025.
- Over the past year, XENE TTM operating profit has dropped by -$68.95 million (-30.78%).
- XENE TTM operating profit is now -2338.31% below its all-time high of $13.09 million, reached on September 30, 2014.
Performance
XENE TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
XENE Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.5% | -23.2% | -30.8% |
| 3 y3 years | -253.6% | -318.8% | -264.9% |
| 5 y5 years | -552.3% | -805.5% | -649.5% |
XENE Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -253.6% | at low | -318.8% | +6.1% | -264.9% | at low |
| 5 y | 5-year | -792.3% | at low | <-9999.0% | +6.1% | -902.5% | at low |
| alltime | all time | -2614.8% | at low | -939.8% | +6.1% | -2338.3% | at low |
XENE Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$72.74M(-6.1%) | -$293.00M(+4.9%) |
| Dec 2024 | -$279.30M(+30.5%) | -$77.48M(+5.2%) | -$279.30M(+9.3%) |
| Sep 2024 | - | -$73.68M(+6.6%) | -$255.52M(+7.6%) |
| Jun 2024 | - | -$69.10M(+17.0%) | -$237.52M(+6.0%) |
| Mar 2024 | - | -$59.04M(+10.0%) | -$224.04M(+4.7%) |
| Dec 2023 | -$214.05M(+65.7%) | -$53.70M(-3.6%) | -$214.05M(+5.1%) |
| Sep 2023 | - | -$55.68M(+0.1%) | -$203.69M(+9.4%) |
| Jun 2023 | - | -$55.62M(+13.4%) | -$186.13M(+15.7%) |
| Mar 2023 | - | -$49.05M(+13.2%) | -$160.82M(+24.5%) |
| Dec 2022 | -$129.14M(+63.5%) | -$43.33M(+13.6%) | -$129.14M(+16.7%) |
| Sep 2022 | - | -$38.13M(+25.8%) | -$110.65M(+25.6%) |
| Jun 2022 | - | -$30.32M(+74.5%) | -$88.12M(+9.7%) |
| Mar 2022 | - | -$17.37M(-30.1%) | -$80.30M(+1.7%) |
| Dec 2021 | -$78.99M(+152.4%) | -$24.84M(+59.2%) | -$78.99M(+17.8%) |
| Sep 2021 | - | -$15.60M(-30.7%) | -$67.08M(+9.6%) |
| Jun 2021 | - | -$22.50M(+40.1%) | -$61.18M(+55.6%) |
| Mar 2021 | - | -$16.06M(+24.3%) | -$39.33M(+25.6%) |
| Dec 2020 | -$31.30M(-26.9%) | -$12.92M(+33.2%) | -$31.30M(+4.4%) |
| Sep 2020 | - | -$9.70M(+1401.4%) | -$29.98M(+2.6%) |
| Jun 2020 | - | -$646.00K(-92.0%) | -$29.23M(-25.2%) |
| Mar 2020 | - | -$8.03M(-30.7%) | -$39.09M(-8.7%) |
| Dec 2019 | -$42.82M | -$11.60M(+29.6%) | -$42.82M(+7.9%) |
| Sep 2019 | - | -$8.95M(-14.8%) | -$39.67M(-11.7%) |
| Jun 2019 | - | -$10.51M(-10.6%) | -$44.91M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$11.76M(+39.1%) | -$41.99M(+10.4%) |
| Dec 2018 | -$38.04M(+16.8%) | -$8.45M(-40.4%) | -$38.04M(+1.1%) |
| Sep 2018 | - | -$14.19M(+86.8%) | -$37.64M(+17.3%) |
| Jun 2018 | - | -$7.59M(-2.7%) | -$32.09M(-0.9%) |
| Mar 2018 | - | -$7.81M(-3.0%) | -$32.39M(-0.6%) |
| Dec 2017 | -$32.58M(+31.3%) | -$8.05M(-6.9%) | -$32.58M(+8.6%) |
| Sep 2017 | - | -$8.64M(+9.5%) | -$29.99M(+4.6%) |
| Jun 2017 | - | -$7.89M(-1.2%) | -$28.67M(+5.6%) |
| Mar 2017 | - | -$7.99M(+46.2%) | -$27.15M(+9.4%) |
| Dec 2016 | -$24.82M(+165.1%) | -$5.46M(-25.5%) | -$24.82M(+13.0%) |
| Sep 2016 | - | -$7.33M(+15.2%) | -$21.96M(+42.2%) |
| Jun 2016 | - | -$6.37M(+12.5%) | -$15.45M(+73.9%) |
| Mar 2016 | - | -$5.66M(+117.4%) | -$8.88M(-5.1%) |
| Dec 2015 | -$9.36M(-184.3%) | -$2.60M(+217.4%) | -$9.36M(+39.2%) |
| Sep 2015 | - | -$820.00K(-512.1%) | -$6.72M(-343.8%) |
| Jun 2015 | - | $199.00K(-103.2%) | $2.76M(-29.9%) |
| Mar 2015 | - | -$6.14M(<-9900.0%) | $3.94M(-64.6%) |
| Dec 2014 | $11.11M(+14.4%) | $35.00K(-99.6%) | $11.11M(-15.2%) |
| Sep 2014 | - | $8.66M(+528.5%) | $13.09M(+19.6%) |
| Jun 2014 | - | $1.38M(+33.5%) | $10.95M(+14.4%) |
| Mar 2014 | - | $1.03M(-48.9%) | $9.57M(+12.1%) |
| Dec 2013 | $9.71M(-408.0%) | $2.02M(-69.0%) | $8.54M(+31.0%) |
| Sep 2013 | - | $6.52M | $6.52M |
| Dec 2012 | -$3.15M(-74.0%) | - | - |
| Dec 2011 | -$12.11M | - | - |
FAQ
- What is Xenon Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual operating profit year-on-year change?
- What is Xenon Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly operating profit year-on-year change?
- What is Xenon Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals TTM operating profit year-on-year change?
What is Xenon Pharmaceuticals annual operating income?
The current annual operating profit of XENE is -$279.30M
What is the all time high annual operating profit for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual operating income is $11.11M
What is Xenon Pharmaceuticals annual operating profit year-on-year change?
Over the past year, XENE annual operating income has changed by -$65.24M (-30.48%)
What is Xenon Pharmaceuticals quarterly operating income?
The current quarterly operating profit of XENE is -$72.74M
What is the all time high quarterly operating profit for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly operating income is $8.66M
What is Xenon Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, XENE quarterly operating income has changed by -$13.70M (-23.20%)
What is Xenon Pharmaceuticals TTM operating income?
The current TTM operating profit of XENE is -$293.00M
What is the all time high TTM operating profit for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high TTM operating income is $13.09M
What is Xenon Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, XENE TTM operating income has changed by -$68.95M (-30.78%)